Cutaneous fungal infections that generally require systemic antifungal therapy include tinea capitis and onychomycosis. Tinea capitis, which is most often caused by Trichophyton tonsurans ...

Basidiobolomycosis: A fungal infection caused by the organism Basidiobolus ranarum, which can affect the skin, subcutaneous tissues, and gastrointestinal tract. Intussusception: A medical ...

Fungal infection, also known as a mycosis, refers to the invasion of a host's tissue by specific types of fungi. Mycoses often start in the lungs following inhalation of fungal spores or on the ...

A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...

Cutaneous disease is a frequent cause ... primarily superficial fungal and bacterial infections. In a cohort of 142 homeless men staying overnight in a major Boston shelter over a period of ...

Histoplasmosis, coccidioidomycosis and blastomycosis are dimorphic fungal infections. Based on insurance claims, researchers determined that the infections have expanded beyond their typical areas ...

The subcutaneous formulation of Opdivo Qvantig reduces administration time to three to five minutes, compared to 30 minutes for the IV version. This formulation offers increased convenience, ...

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

Sinusitis caused by a fungal infection can also be serious and life threatening. Some serious health conditions can have symptoms that may initially appear similar to sinusitis. If you have concer ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

Impetigo is a bacterial infection that affects your skin, causing sores and blisters. It can appear differently depending on the stage of infection and what part of your body it affects.

Skin and subcutaneous infections were reported with a higher frequency in the tocilizumab (4.1%) than in the methotrexate group (0.7%). The incidence of herpes infection was similar in the two ...